Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.37 |
| ▸ | PRKDC | P78527 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.35 |
| ▸ | SYK | P43405 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20910794 | 0.97 | KIF11 (0.39) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL27022493 | 0.97 | KIF11 (0.40) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL21364838 | 0.97 | KIF11 (0.42) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL20910526 | 0.95 | KIF11 (0.39) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL27022492 | 0.94 | KIF11 (0.38) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL23965880 | 0.94 | KIF11 (0.40) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL20910843 | 0.94 | RXRA (0.36) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL20910657 | 0.94 | KIF11 (0.37) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL20910692 | 0.93 | KIF11 (0.37) | KIF11DGAT1SOAT1KCNH2PTGDR2 | |
| SCHEMBL27016334 | 0.92 | KIF11 (0.38) | KIF11DGAT1SOAT1KCNH2PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10998504-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-05-04 | — | — | US | disclosed |
| US-20190115544-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10998504-B2 | Organic molecules for use in optoelectronic devices | OCIAD1, OCIAD2, POU2F1 | KIF11 451/4885DGAT1 1633/4885SOAT1 2037/4885 |
| US-20190115544-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD1, OCIAD2, POU2F1 | KIF11 451/4885DGAT1 1633/4885SOAT1 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.